WoS İndeksli Yayınlar Koleksiyonu

Permanent URI for this collectionhttps://hdl.handle.net/20.500.14627/6

Browse

Search Results

Now showing 1 - 2 of 2
  • Article
    The Relation Between Personality Traits and Chemotherapy Symptoms of Cancer Patients
    (Marmara Univ, Inst Health Sciences, 2025) Özkan, İlknur; Taylan, Seçil; Eroglu, Nermın; Kolac, Nurcan
    Objective:This study is important as it is one of the first studies to evaluate the relationship between personality traits and symptoms. Methods:This study was planned as descriptive and cross-sectional. The study was conducted with 468 patients who were voluntary to participate in the study and applied to the chemotherapy unit in a private oncology hospital in Istanbul between January-June 2019. Data were obtained using the Patient Information Form, Chemotherapy Symptom Assessment Scale (C-SAS), and Big Five Inventory. Results:The data were evaluated on computer environment. The mean age of the patients was 59.46±11.78 years, 59.8% are female, 35.7% were secondary school graduate, and 36.5% were housewives.When the mean scores of the big five inventory were examined, it was found that the mean scores were 29.72±3.38 in Extraversion subscale, 28.31±5.62 in Agreeableness subscale, 27.14±4.44 in Conscientiousness subscale, 25.26±3.31 in Neuroticism subscale, and 28.31±5.62 in Openness subscale. One-unit increase in neuroticism was determined to increase post-treatment nausea by 1.14 times, diarrhea by 1.28 times, change in sexual life by 1.14 times, feeling pessimistic and sad by 1.071 times, and feeling anxious and distressed by 1.08 times. Conclusion:It was observed that the personality traits of cancer patients were correlated with the symptoms they experienced related to chemotherapy and the symptoms decreased with the increase of openness, extraversion, agreeableness and conscientiousness characteristics and the symptoms increased with the increase of neuroticism characteristic.These results indicated that healthcare professionals should consider personnel characteristics of cancer patients while evaluating the symptoms they experienced and providing care.
  • Article
    Citation - WoS: 3
    Citation - Scopus: 7
    Effect of Peppermint-Lemon Aromatherapy on Nausea-Vomiting and Quality of Life in Pediatric Patients With Leukemia: a Randomized Controlled Trial
    (Elsevier Science inc, 2023) Sanci, Yagmur; Yildiz, Suzan; Aycicek, Ali; Mohur, Naciye
    Background: Nausea and vomiting, frequently induced by chemotherapy, can delay treatment protocols and the healing process. Purpose: The aim of this study is to determine how aromatherapy inhalation with peppermint and lemon using a diffuser affects nausea-vomiting management and quality of life in 2-12-year-old children undergoing chemotherapy. Design and methods: The study utilized a pretest-posttest control group experimental design with randomized groups. A total of 90 children who met the inclusion criteria were included in the study. The experimental group received Mentha Piperita and Citrus Lemon essential oils through a diffuser, while the placebo group received water through a diffuser. The control group did not receive any intervention. Results: Pulse and respiratory rates of children treated with aromatherapy were found to be significantly lower than the other groups. After aromatherapy application, quality of life of the children in the experimental group was significantly higher than the other groups. The change in the Index of Nausea, Vomiting, and Retching scores of the experimental group on the 4th chemotherapy cycle compared to the 1st chemotherapy cycle was significantly higher than the change in the other groups. Conclusions: Consequently, it was determined that inhalation aromatherapy with peppermint-lemon was effective in the management of chemotherapy-induced nausea-vomiting symptoms and quality of life compared to the placebo and control groups. Practice implications: Inhalation aromatherapy with mint-lemon can be used as an alternative method to improve the quality of life in children with leukemia who suffer from chemotherapy-induced nausea and vomiting. (c) 2023 Elsevier Inc. All rights reserved.